Breaking the Cycle of Therapeutic Inertia: How Once-Weekly Insulins and Technology Can Transform Diabetes Care

Overview

Insulin initiation and intensification can be challenging in primary care, yet timely action is critical for patients with type 2 diabetes mellitus (T2DM). Come away with practical strategies to overcome therapeutic inertia, review the role of basal insulin, and evaluate emerging once-weekly formulations to improve patient outcomes in T2DM care.

The session "Breaking the Cycle of Therapeutic Inertia: How Once-Weekly Insulins and Technology Can Transform Diabetes Care" (1.00 hour) is designed to satisfy state licensure requirements in Nutrition and Metabolic Health (MD/PA/NP) in Louisiana

Learning Objectives

• Review the current role and benefits of basal insulin in T2DM management
• Identify barriers to insulin initiation and intensification as well as strategies to overcome these barriers
• Examine the evidence on emerging once-weekly insulins